Ailani, Jessica
Andrews, J. Scott
Rettiganti, Mallikarjuna
Nicholson, Robert A.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 18 August 2020
Accepted: 8 October 2020
First Online: 17 October 2020
Ethics approval and consent to participate
: Stated in Study Design Section of Methods, <i>“Study protocols were reviewed and approved by the appropriate institutional review board for each of the study sites. The studies were conducted according to Good Clinical Practice and the Declaration of Helsinki guidelines. Patients provided written informed consent before undergoing study procedures.”</i>
: Not applicable
: Jessica Alani, <i>CME programing</i>: Miller Communications (CME content and speaker fee), Avent (CME content and speaker fee), Peer View (CME speaker fee), Forefront (CME content and speaker fee); <i>Consultant:</i> (Honoraria for independent consulting) Alder, Amgen, Allergan, Electrocore, Eli Lilly and Company, Promius, Teva, Impel, Satsuma, Zosano, Revance, Alpha Sites Consulting, Neurodiem; <i>Research Support</i>: American Migraine Foundation, Allergan, Biohaven, Eli Lilly and Company; <i>Speaker’s Bureau</i>: (Honoraria for promotional speaking) Allergan, Amgen, Electrocore, Eli Lilly and Company, Promius, Teva; <i>Other</i>: Current pain and headache reports, section editor.J. Scott Andrews, Employee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USA.Mallikarjuna Rettiganti, Employee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USA.Robert A. Nicholson, Employee of Eli Lilly and Company, and/or one of its subsidiaries, Indianapolis, IN, USA.